RT Book, Section A1 Murri, PharmD, MBA, Nelda A2 Brunton, Laurence L. A2 Hilal-Dandan, Randa A2 Knollmann, Björn C. SR Print(0) ID 1179320436 T1 The Goodman & Gilman Year in Review: 2017 New and Noteworthy FDA Approvals T2 Goodman & Gilman's: The Pharmacological Basis of Therapeutics, 13e YR 2017 FD 2017 PB McGraw-Hill Education PP New York, NY SN 9781259584732 LK accessbiomedicalscience.mhmedical.com/content.aspx?aid=1179320436 RD 2024/03/29 AB In 2017 the U.S. Food and Drug Administration (FDA) approved 40 noteworthy new drug products and granted 48 noteworthy new biologic licenses. Among the 40 new drug products are: